ELBIO — Elviemek SA Income Statement
0.000.00%
FinancialsMicro Cap
Annual income statement for Elviemek SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2014 December 31st | 2015 December 31st | R2016 December 31st | 2017 December 31st | 2018 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.859 | 0.718 | 0.001 | 0.002 | 0.002 |
| Cost of Revenue | |||||
| Gross Profit | 0.46 | 0.42 | 0.001 | 0.002 | 0.002 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1.09 | 0.591 | 0.381 | 0.325 | 0.456 |
| Operating Profit | -0.234 | 0.127 | -0.38 | -0.323 | -0.454 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.473 | -0.103 | -0.466 | -0.375 | -0.844 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.473 | -0.103 | -0.466 | -0.375 | -0.844 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -0.473 | -0.103 | -0.128 | 0.033 | -0.657 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.473 | -0.103 | -0.128 | 0.033 | -0.657 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.067 | -0.015 | -0.066 | -0.053 | -0.119 |
| Dividends per Share |